https://endpts.com/bristol-myers-2seventy-roll-out-full-abecma-data-in-earlier-stage-cancer/
0
0
2/10/23 at 8:34pm
Organization
Endpoints News
Author
Paul Schloesser
Bristol Myers Squibb and 2seventy bio teased a top-line win for their BCMA-targeting CAR-T Abecma in earlier stages of multiple myeloma back in August. Now they're offering a look at the full data. The biotech and Big Pharma pair put out word Friday that rela…
Create an account
or login to join the discussion